Panion & Bf Biotech Inc. Stock Price

TWSE:1760 Community·NT$5.6b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

1760 Share Price Performance

NT$65.80

-16.50 (-20.05%)

NT$65.80

-16.50 (-20.05%)

NT$65.80

Tue, 16 Dec 25

Share Pricen/a

1760 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Solid track record with excellent balance sheet.

1 Risk

1 Reward

View Full Analysis

Panion & Bf Biotech Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: 2.03
: 53.74%
: 8.55%
: 31.4%

View Full Analysis

About 1760

Founded: 1974
Employees: n/a
CEO: Tsung-Ming Chiang
WebsiteView website: www.pbf.com.tw

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, Covid-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1974 and is headquartered in Taipei, Taiwan.